The Efficacy and Safety of Botulinum Toxin Type A in Patients with Primary Axillary Hyperhidrosis
Authors:
- Yuichiro OhshimaYOYuichiro Ohshima
- Yasuhiko TamadaYTYasuhiko Tamada
- Hiroo YokozekiHYHiroo Yokozeki
- Toshio MaedaTMToshio Maeda
- Akira EndoAEAkira Endo
- Tomoko SentaTSTomoko Senta
- Tameichiro NagakiTNTameichiro Nagaki
- 1 January 2013
- journal article
- Published by Western Japan Division of JDA in The Nishinihon Journal of Dermatology
- Vol. 75 (4) , 357-364
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- A Comprehensive Approach to the Recognition, Diagnosis, and Severity-Based Treatment of Focal Hyperhidrosis: Recommendations of the Canadian Hyperhidrosis Advisory CommitteeDermatologic Surgery, 2007
- Botulinum toxin type A in the treatment of primary axillary hyperhidrosis: A 52-week multicenter double-blind, randomized, placebo-controlled study of efficacy and safetyJournal of the American Academy of Dermatology, 2007
- Recognition, diagnosis, and treatment of primary focal hyperhidrosisJournal of the American Academy of Dermatology, 2004
- US prevalence of hyperhidrosis and impact on individuals with axillary hyperhidrosis: Results from a national surveyJournal of the American Academy of Dermatology, 2004
- Long-term results of 630 thoracoscopic sympathicotomies for primary hyperhidrosis: the vienna experienceBritish Journal of Surgery, 2003
- Botulinum Toxin Type A Is a Safe and Effective Treatment for Axillary Hyperhidrosis Over 16 MonthsArchives of Dermatology, 2003
- PES13: COMPARING THE QUALITY OF LIFE EFFECTS OF PRIMARY FOCAL HYPERHIDROSIS TO OTHER DERMATOLOGICAL CONDITIONS AS ASSESSED BY THE DERMATOLOGY LIFE QUALITY INDEX (DLQI)Value in Health, 2003
- Hyperhidrosis: A Review of Current ManagementPlastic and Reconstructive Surgery, 2002
- TREATMENT OF HYPERHIDROSISDermatologic Clinics, 1998
- Dermatology Life Quality Index (DLQI)-a simple practical measure for routine clinical useClinical and Experimental Dermatology, 1994